Acorda Therapeutics (ACOR) Institutional Ownership Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for Acorda Therapeutics (NASDAQ:ACOR)CurrentInstitutional OwnershipPercentage12.71%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$8.44M Get ACOR Insider Trade Alerts Want to know when executives and insiders are buying or selling Acorda Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACOR Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Acorda Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/7/2023Acadian Asset Management LLC34,131$442K0.0%-95.0%2.798% 2/10/2022Acadian Asset Management LLC467,739$1.12M0.0%+22.3%4.175% 11/15/2021Point72 Asset Management L.P.468,166$2.15M0.0%-47.3%4.209% 11/12/2021Renaissance Technologies LLC724,718$3.33M0.0%+1.5%6.515% 11/9/2021BlackRock Inc.161,939$744K0.0%-3.2%1.456% 11/1/2021AE Wealth Management LLC40,457$186K0.0%N/A0.364% Get the Latest News and Ratings for ACOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acorda Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/17/2021Virtu Financial LLC10,119$48K0.0%N/A0.091% 8/17/2021Bridgeway Capital Management LLC101,590$485K0.0%+44.3%1.071% 8/16/2021Squarepoint Ops LLC49,269$235K0.0%N/A0.519% 8/16/2021State Street Corp31,648$151K0.0%N/A0.334% 8/13/2021Renaissance Technologies LLC714,118$3.41M0.0%-12.3%7.526% 8/13/2021Geode Capital Management LLC73,562$350K0.0%+13.4%0.775% 8/13/2021Vanguard Group Inc.340,481$1.62M0.0%+25.1%3.588% 8/12/2021Dimensional Fund Advisors LP77,408$369K0.0%+46.4%0.816% 7/31/2021United Asset Strategies Inc.27,100$129K0.0%N/A0.286% 5/18/2021Millennium Management LLC35,067$171K0.0%N/A0.370% 5/18/2021Point72 Asset Management L.P.891,626$4.34M0.0%-1.3%9.396% 5/14/2021Public Employees Retirement System of Ohio21,913$107K0.0%-11.3%0.231% 5/14/2021Dimensional Fund Advisors LP52,862$257K0.0%N/A0.557% 5/13/2021QS Investors LLC50,801$247K0.0%+140.2%0.535% 5/13/2021Renaissance Technologies LLC814,397$3.97M0.0%-80.1%8.583% 5/13/2021Blair William & Co. IL23,840$116K0.0%N/A0.251% 5/13/2021Federated Hermes Inc.106,634$519K0.0%-83.4%1.124% 5/12/2021Northern Trust Corp29,502$144K0.0%-68.6%0.311% 5/12/2021Chilton Capital Management LLC63,781$311K0.0%N/A0.672% 5/12/2021Geode Capital Management LLC64,856$315K0.0%-83.8%0.683% 5/11/2021Acadian Asset Management LLC379,922$1.85M0.0%-81.5%4.004% 5/10/2021Russell Investments Group Ltd.6,000$29K0.0%N/A0.063% 5/7/2021BlackRock Inc.190,210$927K0.0%-82.6%2.005% 2/16/2021Squarepoint Ops LLC60,939$42K0.0%-66.0%0.762% 2/12/2021Federated Hermes Inc.641,178$2.66M0.0%-0.3%8.020% 2/10/2021Renaissance Technologies LLC4,085,285$2.82M0.0%+6.4%51.098% 2/5/2021BlackRock Inc.1,093,359$756K0.0%+0.7%13.676% 2/5/2021Aperio Group LLC35,818$25K0.0%N/A0.448% 1/1/2021Sei Investments Co.72,549$37K0.0%-42.3%0.151% 11/16/2020Point72 Asset Management L.P.2,000,000$1.03M0.0%+6.8%4.170% 11/16/2020Squarepoint Ops LLC179,426$92K0.0%+35.6%0.374% 11/12/2020Arrowstreet Capital Limited Partnership286,500$148K0.0%-51.0%0.597% 11/12/2020Federated Hermes Inc.643,258$331K0.0%-2.7%1.341% 11/9/2020Acadian Asset Management LLC1,835,064$944K0.0%-1.4%3.826% 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here11/6/2020Sei Investments Co.72,549$37K0.0%-42.3%0.151% 11/6/2020BlackRock Inc.1,086,230$559K0.0%-5.2%2.264% 11/6/2020GSA Capital Partners LLP672,158$346K0.1%+1,145.6%1.401% 11/6/2020Blair William & Co. IL143,035$74K0.0%+166.1%0.298% 8/31/2020Bridgeway Capital Management Inc.345,106$254K0.0%+81.5%0.719% 8/20/2020Charles Schwab Investment Management Inc.192,276$142K0.0%-38.0%0.401% 8/17/2020AQR Capital Management LLC961,460$706K0.0%+8.9%2.004% 8/17/2020Jane Street Group LLC260,005$191K0.0%N/A0.542% 8/14/2020Point72 Asset Management L.P.1,872,182$1.38M0.0%+17.8%3.902% 8/14/2020Bank of America Corp DE69,718$51K0.0%+405.9%0.145% 8/13/2020Federated Hermes Inc.661,132$486K0.0%+45.0%1.378% 8/12/2020Blair William & Co. IL53,750$39K0.0%N/A0.112% 8/5/2020Russell Investments Group Ltd.97,138$71K0.0%+83.3%0.202% 6/19/2020State Street Corp1,492,994$1.39M0.0%+1.6%3.111% 6/16/2020Royal Bank of Canada32,826$30K0.0%+571.7%0.068% (Data available from 1/1/2016 forward) ACOR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACOR shares? During the previous two years, the following institutional investors and hedge funds held shares of Acorda Therapeutics shares: Acadian Asset Management LLC ($442K).Learn more on ACOR's institutional investors. What percentage of Acorda Therapeutics stock is owned by institutional investors? 12.71% of Acorda Therapeutics stock is owned by institutional investors. Learn more on ACOR's institutional investor holdings. Which Acorda Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Acorda Therapeutics stock in the last 24 months: Acadian Asset Management LLC ($648.51K). How much institutional selling is happening at Acorda Therapeutics? Institutional investors have sold a total of 648,507 shares in the last 24 months. This volume of shares sold represents approximately $8.44M in transactions. Related Companies: LIFE Institutional Ownership OCGN Institutional Ownership AMGN Institutional Ownership VRTX Institutional Ownership REGN Institutional Ownership GILD Institutional Ownership BIIB Institutional Ownership ALNY Institutional Ownership BMRN Institutional Ownership NBIX Institutional Ownership This page (NASDAQ:ACOR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acorda Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acorda Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
